Changchun BCHT Biotechnology Co. (SHA:688276)
China · Delayed Price · Currency is CNY 15.45
-0.56 (-3.50%)
Nov 13, 2026, 3:00 PM CST
SHA:688276 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 230.93 | 201.24 | 344.87 | 442.18 | 866.54 | 1,156 |
Cash & Short-Term Investments | 230.93 | 201.24 | 344.87 | 442.18 | 866.54 | 1,156 |
Cash Growth | 46.68% | -41.65% | -22.01% | -48.97% | -25.01% | 273.22% |
Accounts Receivable | 960.7 | 936.82 | 1,407 | 1,567 | 968.41 | 763.94 |
Other Receivables | 2.41 | - | - | - | - | - |
Receivables | 963.11 | 936.82 | 1,407 | 1,567 | 968.41 | 763.94 |
Inventory | 277.14 | 226.55 | 170.78 | 199.02 | 192.11 | 241.34 |
Prepaid Expenses | - | 1.08 | 1.11 | 0.92 | 0.1 | - |
Other Current Assets | 78.87 | 57.23 | 41.21 | 35.26 | 30.81 | 29.15 |
Total Current Assets | 1,550 | 1,423 | 1,965 | 2,245 | 2,058 | 2,190 |
Property, Plant & Equipment | 2,590 | 2,613 | 2,478 | 2,085 | 1,642 | 1,439 |
Long-Term Investments | 325.3 | 364.35 | 211.34 | 207.57 | 61.28 | 69.12 |
Other Intangible Assets | 279.97 | 320.62 | 330.6 | 347.45 | 204.02 | 223.72 |
Long-Term Deferred Tax Assets | 190.92 | 163.56 | 96.28 | 90.97 | 54.2 | 31.93 |
Long-Term Deferred Charges | 180.12 | 153.95 | 74.68 | 29.26 | 211.09 | 159.25 |
Other Long-Term Assets | 33.3 | 30.12 | 49.56 | 41.06 | 53.06 | 61.95 |
Total Assets | 5,150 | 5,068 | 5,205 | 5,046 | 4,284 | 4,175 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 37.3 | 19.6 | 13.81 | 17.49 | 24.8 | 63.91 |
Accrued Expenses | 32.12 | 520.8 | 533.19 | 553.18 | 340.9 | 422.69 |
Short-Term Debt | 396.29 | 181.19 | 42.9 | 20.47 | - | - |
Current Portion of Long-Term Debt | 48.23 | 20.47 | - | - | - | - |
Current Income Taxes Payable | - | - | - | 48.89 | 5.07 | - |
Current Unearned Revenue | 8.74 | 11.92 | 2.2 | 0.28 | 8.65 | 10.21 |
Other Current Liabilities | 759.94 | 350.87 | 324.97 | 374.56 | 337.27 | 251.89 |
Total Current Liabilities | 1,283 | 1,105 | 917.07 | 1,015 | 716.68 | 748.71 |
Long-Term Debt | 68.78 | 63.58 | 59.93 | - | - | - |
Long-Term Unearned Revenue | 48.62 | 48.26 | 9 | 9.86 | 5.92 | 8.09 |
Long-Term Deferred Tax Liabilities | 0.66 | 0.78 | 0.88 | 0.98 | 1.11 | - |
Other Long-Term Liabilities | 0.01 | 0 | 0.24 | 0.17 | 0.31 | 0.25 |
Total Liabilities | 1,401 | 1,217 | 987.12 | 1,026 | 724.02 | 757.05 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 413.66 | 413.66 | 413.66 | 412.84 | 412.84 | 412.84 |
Additional Paid-In Capital | - | 1,818 | 1,840 | 1,820 | 1,778 | 1,771 |
Retained Earnings | 1,561 | 1,656 | 1,989 | 1,819 | 1,380 | 1,240 |
Comprehensive Income & Other | 1,774 | -36.83 | -25.27 | -31.86 | -10.96 | -5.75 |
Shareholders' Equity | 3,749 | 3,851 | 4,218 | 4,020 | 3,560 | 3,418 |
Total Liabilities & Equity | 5,150 | 5,068 | 5,205 | 5,046 | 4,284 | 4,175 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 513.3 | 265.24 | 102.83 | 20.47 | - | - |
Net Cash (Debt) | -282.38 | -64 | 242.04 | 421.71 | 866.54 | 1,156 |
Net Cash Growth | - | - | -42.60% | -51.33% | -25.01% | 273.22% |
Net Cash Per Share | -0.69 | -0.16 | 0.58 | 1.02 | 2.10 | 2.94 |
Filing Date Shares Outstanding | 445.75 | 413.66 | 413.66 | 412.84 | 412.84 | 412.84 |
Total Common Shares Outstanding | 445.75 | 413.66 | 413.66 | 412.84 | 412.84 | 412.84 |
Working Capital | 267.42 | 318.08 | 1,048 | 1,230 | 1,341 | 1,441 |
Book Value Per Share | 8.41 | 9.31 | 10.20 | 9.74 | 8.62 | 8.28 |
Tangible Book Value | 3,469 | 3,530 | 3,887 | 3,673 | 3,356 | 3,194 |
Tangible Book Value Per Share | 7.78 | 8.53 | 9.40 | 8.90 | 8.13 | 7.74 |
Buildings | - | 560.43 | 547.95 | 487.92 | 374.62 | 307.51 |
Machinery | - | 942.43 | 945.82 | 826.34 | 509.79 | 451.85 |
Construction In Progress | - | 1,601 | 1,386 | 1,101 | 1,038 | 919.84 |